Cargando…

Is neuroendocrine differentiation a prognostic factor in poorly differentiated colorectal cancer?

BACKGROUND: To determine the prognostic relevance of neuroendocrine differentiation in poorly differentiated colorectal cancer. METHODS: The clinicopathological features and survival of 70 patients with poorly differentiated colorectal cancer were analyzed retrospectively. Chromogranin A and synapto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yue, Liu, Fang, Meng, Qingkai, Ma, Siping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370452/ https://www.ncbi.nlm.nih.gov/pubmed/28351413 http://dx.doi.org/10.1186/s12957-017-1139-y

Ejemplares similares

Neuroendocrine Differentiation Is a Prognostic Factor for Stage II Poorly Differentiated Colorectal Cancer
por: Liu, Yue, et al.
Publicado: (2014)

Neuroendocrine differentiation is predictive of poor survival in patients with stage II colorectal cancer
por: Liu, Yue, et al.
Publicado: (2017)

Neuroendocrine differentiation: a risk fellow in colorectal cancer
por: Chen, Yue, et al.
Publicado: (2023)

Tumor Differentiation is the Dominant Prognostic Factor for Patients with Colorectal Neuroendocrine Neoplasms with Distant Metastasis
por: Wang, Zhijie, et al.
Publicado: (2022)

Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas
por: Lee, Sun Mi, et al.
Publicado: (2021)

Poorly differentiated clusters and tumor budding are important prognostic factors in colorectal carcinomas
por: Jurescu, Aura, et al.
Publicado: (2022)

Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker?
por: Konukiewitz, Björn, et al.
Publicado: (2021)

The predictive and prognostic value of sex in localized colorectal cancer: a SEER-based analysis
por: Ma, Bin, et al.
Publicado: (2021)

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
por: Mitry, E, et al.
Publicado: (1999)

Clinicopathological Characteristics and Prognostic Factors of Patients with Gastric Cancer Accompanying Neuroendocrine Differentiation (NEDGC)
por: Wang, Ya-Ping, et al.
Publicado: (2020)

Neuroendocrine Differentiation in Sporadic CRC and Hereditary Nonpolyosis Colorectal Cancer
por: Sun, M. H.
Publicado: (2004)

Rare Occurrence of a Poorly Differentiated Neuroendocrine Tumor of the Bladder
por: Dowd, Katherine, et al.
Publicado: (2017)

A Poorly Differentiated Esophageal Neuroendocrine Carcinoma With Brain Metastasis
por: Swied, Muhammed Yaman, et al.
Publicado: (2023)

Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms
por: Han, Deng, et al.
Publicado: (2021)

Poorly differentiated large-cell neuroendocrine carcinoma of the paranasal sinus
por: Campos, Helder Groenwold, et al.
Publicado: (2018)

Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma
por: Wang, Haihong, et al.
Publicado: (2020)

HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2021)

Efficacy of topotecan in pretreated metastatic poorly differentiated extrapulmonary neuroendocrine carcinoma
por: Apostolidis, Leonidas, et al.
Publicado: (2016)

Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms
por: Jiang, Mengjie, et al.
Publicado: (2017)

ODP020 A Challenging Case of Poorly Differentiated Carcinoma with Neuroendocrine Differentiation and Adrenal Mass
por: Mosquera, Jorge, et al.
Publicado: (2022)

Leptin Overexpression as a Poor Prognostic Factor for Colorectal Cancer
por: Li, Chunxiang, et al.
Publicado: (2020)

Combination of Irinotecan and a Platinum Agent for Poorly Differentiated Neuroendocrine Carcinomas
por: Ramella Munhoz, Rodrigo, et al.
Publicado: (2013)

Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors
por: Lamberti, G., et al.
Publicado: (2017)

Prognostic value of poorly differentiated clusters in invasive breast cancer
por: Sun, Ying, et al.
Publicado: (2014)

Primary poorly differentiated small cell type neuroendocrine carcinoma of the hypopharynx
por: Ao, Yin-Jie, et al.
Publicado: (2019)

Surgical palliation in poorly differentiated neuroendocrine carcinoma of the hypopharynx: Case report
por: Fiorini, Francesca Romana, et al.
Publicado: (2021)

Selection of Chemotherapy in Advanced Poorly Differentiated Extra-Pulmonary Neuroendocrine Carcinoma
por: Weaver, Jamie M. J., et al.
Publicado: (2023)

Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report
por: Lin, Hung-Hsin, et al.
Publicado: (2016)

Prognostic Impact of Microsatellite Instability in Colorectal Cancer Presenting With Mucinous, Signet-Ring, and Poorly Differentiated Cells
por: Jung, Sang Hun, et al.
Publicado: (2016)

Efficacy of neoadjuvant endocrine therapy in patients with poorly differentiated neuroendocrine carcinoma of the breast: A case report
por: Zhang, Yonglin, et al.
Publicado: (2020)

Prognostic factors of primary neuroendocrine breast cancer: A population‐based study
por: Ma, Shu‐tao, et al.
Publicado: (2022)

Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter Analysis
por: Lamberti, Giuseppe, et al.
Publicado: (2020)

Poorly Differentiated Large Cell Neuroendocrine Carcinoma of the Colon: A Case Report
por: Felux, Kelsee, et al.
Publicado: (2022)

Everolimus in poorly differentiated neuroendocrine carcinoma of unknown primary: A case report
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

hPG(80) (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors
por: Chauhan, Aman, et al.
Publicado: (2022)

Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle
por: Berruti, Alfredo, et al.
Publicado: (2010)

Prediction model of poorly differentiated colorectal cancer (CRC) based on gut bacteria
por: Qi, Zhang, et al.
Publicado: (2022)

Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients
por: Walczyk, Agnieszka, et al.
Publicado: (2020)

Fecal Bacteria as Non-Invasive Biomarkers for Colorectal Adenocarcinoma
por: Yuan, Biao, et al.
Publicado: (2021)

Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer
por: Fujiyoshi, Kenji, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ss2hr6ud8gng9qrd16lii0nbaq